Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: MicroRNA-95-3p serves as a contributor to cisplatin resistance in human gastric cancer cells by targeting EMP1/PI3K/AKT signaling

1. A state-of-art of underlying molecular mechanisms and pharmacological interventions/nanotherapeutics for cisplatin resistance in gastric cancer

   Jitendra Gupta, Abdulrahman T. Ahmed, Nahla A. Tayyib +7

   Шарҳ мақолаMicroRNA in disease regulationBiomedicine & Pharmacotherapy20230 иқтибос

   ABIABI:AkademIndex/openalex/2023.review-article.000032

2. A comprehension of signaling pathways and drug resistance; an insight into the correlation between microRNAs and cancer

   Hashem O. Alsaab, Bekhzod Abdullaev, Adnan Taan Alkhafaji +7

   Шарҳ мақолаMicroRNA in disease regulationPathology - Research and Practice20230 иқтибос

   ABIABI:AkademIndex/openalex/2023.review-article.000094